Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Luci vs Luvo Health

Luci
Graded #101

Higher grade

vs+10
Luvo Health
Graded #305

Lower grade

The verdict

Luci takes it — 71/100 to 61/100.

Luci grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Luci is a budget-focused GLP-1 telehealth platform offering compounded medications with upfront pricing: compounded semaglutide as low as $99/month and compounded tirzepatide as low as $145/month, plus oral…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLuci +46
84
38
Dose & formulationLuvo Health +13
75
88
Clinical oversightLuci +3
71
68
Labs & monitoringLuci +1
53
52
FulfillmentLuvo Health +4
70
74
Contract termsLuci +10
55
45
Luci · left barLuvo Health · right bar

The numbers

MetricLuciLuvo Health
WeighScore71/10061/100
GradeCC
Scorecard rank#101#305
Semaglutide$99/mo (starting dose, promotional rate, compounded)$249/mo (compounded)
Tirzepatide$145/mo (starting dose, promotional rate, compounded)$339/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesYes
Luci

Graded #101 · C

Strengths

  • Budget-friendly compounded GLP-1 pricing (compounded semaglutide as low as $99/month, tirzepatide as low as $145/month)
  • Multiple formats: compounded semaglutide and tirzepatide injections plus oral semaglutide and tirzepatide pill kits
  • Upfront pricing with no insurance required and a fast 3-minute questionnaire to start
  • Care delivered through DrTelx, an independent US telehealth medical group, with ongoing support and dose optimization
  • HIPAA-compliant platform with a large self-reported member base (50,000+)

Where it loses points

  • Compounded medications are not FDA-approved for weight loss (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Available only in select U.S. states, and the full state list is not published
  • The compounding pharmacy partner is not named
  • Headline prices are 'as low as' rates (asterisked) — your actual monthly cost may be higher
  • No LegitScript certification displayed; marketing leans heavily on testimonials
Luvo Health

Graded #305 · C

Strengths

  • Full price list published openly, by medication and by commitment length, with no intake required
  • Offers both compounded and brand-name Ozempic and Zepbound in one place
  • Oral semaglutide tablets available as well as injections
  • Full refund if a provider disqualifies you before medication is ordered
  • LegitScript certification verified against the issued seal, not just the badge

Where it loses points

  • Billed per 4 weeks, not per month, which is 13 charges a year rather than 12
  • You are charged for the first period as soon as you complete the intake form, before a clinician has reviewed you
  • Refunds stop once medication is ordered, and for new patients with no video visit that is at intake submission
  • Cancellation needs 72 hours notice before the billing date or you are charged for another cycle
  • Bundle refunds are recalculated at the standard non-bundled rate, so the multi-month discount is clawed back

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard